Illumina Sketches Strategy to Push NGS into Reproductive Health, Disease ... GenomeWeb HLA typing represents another $300 million market opportunity, according to the company. Illumina has already started to penetrate some of these new markets, as evidenced by a shift in its customer base. Over the last five years, Illumina's revenue ... |
